ENTITY
Celltrion Inc

Celltrion Inc (068270 KS)

476
Analysis
Health CareSouth Korea
Celltrion Inc. produces and sells biosimilar products and also provides consignm ent processing service for other companies. The Company's main product is Abata cept which is for arthritis treatment
more
Refresh
31 Dec 2016 06:11

Korea Stock Market Monthly Recap #9 - (December 2016)

The economic hope post Trump win continued to play out in the global equity markets in December. Dow Jones Industrial Average was up 3.3% and...

Logo
460 Views
Share
27 Dec 2016 13:07

Celltrion Healthcare IPO - Early Review on Key Issues

Celltrion Healthcare, which is Celltrion (068270)’s overseas sales and marketing unit, submitted the application for preliminary screening for...

Logo
261 Views
Share
26 Dec 2016 16:13

Free Cash Flow Remains King in Weeding Out the Winners and Losers

The Korean Stock Market remains surprisingly fundamental driven and free cash flow remains a fundamental factor that could help investors to weed...

Logo
268 Views
Share
23 Dec 2016 07:38

Weeding Out the Chaff for Portfolio Outperformance in 2017

Investors prefer companies that can consistently grow their sales and profits, at reasonable valuations. In this report, we selected 72 companies...

Logo
196 Views
Share
08 Dec 2016 08:24

MediSetter Interview: Insight on Opportunities in Asia's Healthcare Industry

Introduction to MedisetterI had the pleasure of interviewing Anirban Lahiri of Medisetter to discuss some of the opportunities present in Asia's...

Share
x